Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$28.4B
1-Year Return
37.22%
This Quarter Return
-14.29%
1 Year Return
+37.22%
3 Year Return
+93.7%
5 Year Return
+199.54%
10 Year Return
+398.51%
AUM
$16.5B
AUM Growth
-$3.93B
(-19%)
Cap. Flow
-$694M
Cap. Flow
% of AUM
-4.21%
Top 10 Holdings %
Top 10 Hldgs %
32.53%
Holding
1,265
New
250
Increased
403
Reduced
360
Closed
243
Top Buys
| 1 |
Canadian National Railway
CNI
|
$83.7M |
| 2 |
Restaurant Brands International
QSR
|
$59.5M |
| 3 |
Brookfield Infrastructure Partners
BIP
|
$57.7M |
| 4 |
AstraZeneca
AZN
|
$55.8M |
| 5 |
Algonquin Power & Utilities
AQN
|
$50.7M |
Top Sells
| 1 |
Apple
AAPL
|
$144M |
| 2 |
Royal Bank of Canada
RY
|
$95M |
| 3 |
VRN
Veren
VRN
|
$81.5M |
| 4 |
Wheaton Precious Metals
WPM
|
$73.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$72.5M |
Sector Composition
| 1 | Financials | 27.58% |
| 2 | Energy | 14.57% |
| 3 | Industrials | 13.16% |
| 4 | Technology | 10.16% |
| 5 | Materials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
SunCoke Energy
SXC
$667M
| $245K | ﹤0.01% |
+35,938
| New | +$245K |
|
|
NSTG
902
DELISTED
NanoString Technologies, Inc.
NSTG
| $244K | ﹤0.01% |
+19,190
| New | +$244K |
|
903
CMS Energy
CMS
$21.4B
| $243K | ﹤0.01% |
+3,597
| New | +$243K |
|
904
AMES National
ATLO
$179M
| $241K | ﹤0.01% |
10,885
-4,231
| -28% | -$93.7K |
|
905
Cannae Holdings
CNNE
$1.09B
| $238K | ﹤0.01% |
+12,327
| New | +$238K |
|
|
EVBN
906
DELISTED
Evans Bancorp Inc
EVBN
| $238K | ﹤0.01% |
7,009
-327
| -4% | -$11.1K |
|
907
Revolution Medicines
RVMD
$7.57B
| $235K | ﹤0.01% |
+12,033
| New | +$235K |
|
908
Blackbaud
BLKB
$3.23B
| $231K | ﹤0.01% |
+3,976
| New | +$231K |
|
909
Future Fuel
FF
$173M
| $227K | ﹤0.01% |
31,145
-35,708
| -53% | -$260K |
|
910
Stoke Therapeutics
STOK
$1.13B
| $227K | ﹤0.01% |
17,161
+5,204
| +44% | +$68.8K |
|
911
LGI Homes
LGIH
$1.55B
| $224K | ﹤0.01% |
+2,576
| New | +$224K |
|
912
Puma Biotechnology
PBYI
$253M
| $221K | ﹤0.01% |
77,591
-13,140
| -14% | -$37.4K |
|
913
Adeia
ADEA
$1.69B
| $220K | ﹤0.01% |
+57,539
| New | +$220K |
|
914
Savara
SVRA
$643M
| $220K | ﹤0.01% |
144,432
+9,363
| +7% | +$14.3K |
|
915
Tidewater
TDW
$2.86B
| $219K | ﹤0.01% |
10,406
-6,466
| -38% | -$136K |
|
916
Kodiak Sciences
KOD
$556M
| $216K | ﹤0.01% |
28,306
+15,267
| +117% | +$117K |
|
|
TRHC
917
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $216K | ﹤0.01% |
83,927
+744
| +0.9% | +$1.92K |
|
918
Rexford Industrial Realty
REXR
$10.2B
| $215K | ﹤0.01% |
+3,735
| New | +$215K |
|
919
Henry Schein
HSIC
$8.42B
| $214K | ﹤0.01% |
+2,794
| New | +$214K |
|
920
Lineage Cell Therapeutics
LCTX
$279M
| $214K | ﹤0.01% |
135,328
+123,328
| +1,028% | +$195K |
|
921
RLX Technology
RLX
$3.18B
| $214K | ﹤0.01% |
100,578
+3,305
| +3% | +$7.03K |
|
922
ResMed
RMD
$40.6B
| $214K | ﹤0.01% |
1,023
-662
| -39% | -$138K |
|
|
XNET
923
Xunlei
XNET
$479M
| $213K | ﹤0.01% |
134,763
+49,524
| +58% | +$78.3K |
|
924
Anterix
ATEX
$412M
| $212K | ﹤0.01% |
5,169
-435
| -8% | -$17.8K |
|
925
Ecopetrol
EC
$18.7B
| $212K | ﹤0.01% |
+19,511
| New | +$212K |
|